Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

A New Mechanism for Primary Resistance to Gefitinib in Lung Adenocarcinoma: The Role of a Novel G796A Mutation in Exon 20 of EGFR

HIDETAKA URAMOTO, TAKESHI UCHIUMI, HIROTO IZUMI, KIMITOSHI KOHNO, TSUNEHIRO OYAMA, KENJI SUGIO and KOSEI YASUMOTO
Anticancer Research July 2007, 27 (4B) 2297-2303;
HIDETAKA URAMOTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKESHI UCHIUMI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROTO IZUMI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KIMITOSHI KOHNO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TSUNEHIRO OYAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENJI SUGIO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kensugio@med.uoeh-u.ac.jp
KOSEI YASUMOTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 4B 2297-2303
PubMed 
17695517

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received January 19, 2007
  • Revision received March 22, 2007
  • Accepted March 27, 2007
  • Published online July 1, 2007.

Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. HIDETAKA URAMOTO1,
  2. TAKESHI UCHIUMI2,
  3. HIROTO IZUMI2,
  4. KIMITOSHI KOHNO2,
  5. TSUNEHIRO OYAMA3,
  6. KENJI SUGIO1 and
  7. KOSEI YASUMOTO1
  1. 1Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan
  2. 2Department of Molecular Biology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan
  3. 3Department of Environmental Health, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan
  1. Correspondence to: Kenji Sugio, Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan. Tel: +81 93 691 7442, Fax: +81 93 692 4004, e-mail: kensugio{at}med.uoeh-u.ac.jp

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 27 (4B)
Anticancer Research
Vol. 27, Issue 4B
July-August 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A New Mechanism for Primary Resistance to Gefitinib in Lung Adenocarcinoma: The Role of a Novel G796A Mutation in Exon 20 of EGFR
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A New Mechanism for Primary Resistance to Gefitinib in Lung Adenocarcinoma: The Role of a Novel G796A Mutation in Exon 20 of EGFR
HIDETAKA URAMOTO, TAKESHI UCHIUMI, HIROTO IZUMI, KIMITOSHI KOHNO, TSUNEHIRO OYAMA, KENJI SUGIO, KOSEI YASUMOTO
Anticancer Research Jul 2007, 27 (4B) 2297-2303;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
A New Mechanism for Primary Resistance to Gefitinib in Lung Adenocarcinoma: The Role of a Novel G796A Mutation in Exon 20 of EGFR
HIDETAKA URAMOTO, TAKESHI UCHIUMI, HIROTO IZUMI, KIMITOSHI KOHNO, TSUNEHIRO OYAMA, KENJI SUGIO, KOSEI YASUMOTO
Anticancer Research Jul 2007, 27 (4B) 2297-2303;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Lack of Direct Association between EGFR Mutations and ER Beta Expression in Lung Cancer
  • EGFR-Activating Mutations Are Not Present in Breast Tumors of Japanese Patients
  • Google Scholar

More in this TOC Section

  • MAP17 as a Mediator of HGF-induced Proliferation and Invasion in Gastric Cancer
  • Contribution of Methylenetetrahydrofolate Reductase Genotypes to Brain Tumor Risk Determination in Taiwan
  • Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Reduces Aggressiveness of Cervical Carcinoma Cells
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire